Microbiologic quality assurance for intravenous admixtures in a small hospital

American Journal of Hospital Pharmacy
|May 1, 1982
PubMed

Insights

A new, cost-effective method for testing intravenous (IV) admixtures for microbial contamination was developed. This simple membrane filtration technique accurately detects low-level contamination, ensuring IV product safety.

Area of Science:

  • Microbiology
  • Pharmaceutical Science
  • Quality Control

Background:

  • Microbial contamination of intravenous (IV) admixtures poses a significant risk to patient safety.
  • Existing methods for end-product testing can be costly and complex.
  • Hospital pharmacists require simple, reliable methods for quality assurance.

Purpose of the Study:

  • To develop and validate a simple, inexpensive method for end-product testing of IV admixtures for microbial contamination.
  • To assess the accuracy and cost-effectiveness of the developed method.
  • To provide hospital pharmacists with a practical quality assurance tool.

Main Methods:

  • A 16-step total-sample membrane filtration procedure using a 0.2-micrometer filter unit was established.
  • Intravenous admixtures were deliberately contaminated with low concentrations of Klebsiella pneumoniae and Pseudomonas aeruginosa.
  • Filtration was performed on a laboratory bench, and filters were incubated on sheep-blood agar.
  • Control groups included sterile saline inoculations and uninoculated solutions.

Main Results:

  • The membrane filtration method successfully isolated a mean of 82% of deliberately inoculated organisms.
  • Five instances of adventitious contamination were observed across all 288 samples.
  • The cost per sample was determined to be between $4 and $5.

Conclusions:

  • The developed membrane filtration method is a simple, accurate, and cost-effective approach for end-product testing of IV admixtures.
  • This method provides hospital pharmacists with a viable tool for quality assurance and documentation.
  • The system effectively detects low levels of microbial contamination, enhancing patient safety.

Related Concept Videos

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Dosage Interval and Administration Route: Determination Methods01:19

Dosage Interval and Administration Route: Determination Methods

A medication’s effectiveness largely depends on its appropriate dosage and the route of administration. Dosage ensures that a sufficient drug concentration is maintained in the bloodstream to elicit the desired therapeutic effect without causing toxicity. The route of administration affects the drug's bioavailability, rate of absorption, and onset of action, which are crucial for achieving optimal therapeutic outcomes. Drug dosage calculations are critical to tailoring therapy to individual...
Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...